{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:25:38Z","timestamp":1787685938840,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,25]]},"DOI":"10.7759\/cureus.115169","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:15:16Z","timestamp":1787685316000},"source":"Crossref","is-referenced-by-count":0,"title":["Plasma Homocysteine as a Biomarker for Cardiovascular Risk Stratification in Children and Adolescents With Type 1 Diabetes Mellitus: A Cross-Sectional Study From Western Algeria"],"prefix":"10.7759","author":[{"given":"Auda","family":"Ameur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charef","family":"Latroch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Naas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Amraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacera","family":"Aribi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bouziane Nedjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S014","article-title":"14. Children and adolescents: standards of care in diabetes-2026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes. 14. Children and adolescents: standards of care in diabetes-2026. Diabetes Care. 2026, 49:S297-320. 10.2337\/dc26-S014","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12737","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes","volume":"19 Suppl 27","author":"DiMeglio LA","year":"2018","unstructured":"DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018, 19 Suppl 27:105-14. 10.1111\/pedi.12737","journal-title":"Pediatr Diabetes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13455","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes","volume":"23","author":"de Bock M","year":"2022","unstructured":"de Bock M, Codner E, Craig ME, et al.. ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes. 2022, 23:1270-6. 10.1111\/pedi.13455","journal-title":"Pediatr Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13444","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes","volume":"23","author":"Bjornstad P","year":"2022","unstructured":"Bjornstad P, Dart A, Donaghue KC, et al.. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes. 2022, 23:1432-50. 10.1111\/pedi.13444","journal-title":"Pediatr Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani A","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, et al.. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017, 376:1407-18. 10.1056\/NEJMoa1608664","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12742","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: microvascular and macrovascular complications in children and adolescents","volume":"19 Suppl 27","author":"Donaghue KC","year":"2018","unstructured":"Donaghue KC, Marcovecchio ML, Wadwa RP, et al.. ISPAD Clinical Practice Consensus Guidelines 2018: microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes. 2018, 19 Suppl 27:262-74. 10.1111\/pedi.12742","journal-title":"Pediatr Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108591","article-title":"Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT\/EDIC study","volume":"171","author":"Bebu I","year":"2021","unstructured":"Bebu I, Braffett BH, Orchard TJ, Lorenzi GM, Nathan DM, Herman WH, Lachin JM. Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT\/EDIC study. Diabetes Res Clin Pract. 2021, 171:108591. 10.1016\/j.diabres.2020.108591","journal-title":"Diabetes Res Clin Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2022.882504","article-title":"Interventions to decrease carotid-intima media thickness in children and adolescents with type 1 diabetes: a systematic review and meta-analysis","volume":"3","author":"Epure AM","year":"2022","unstructured":"Epure AM, Anker D, Di Bernardo S, da Costa BR, Sekarski N, Chiolero A. Interventions to decrease carotid-intima media thickness in children and adolescents with type 1 diabetes: a systematic review and meta-analysis. Front Clin Diabetes Healthc. 2022, 3:882504. 10.3389\/fcdhc.2022.882504","journal-title":"Front Clin Diabetes Healthc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1109445","article-title":"Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis","volume":"9","author":"Yuan D","year":"2022","unstructured":"Yuan D, Chu J, Lin H, et al.. Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis. Front Cardiovasc Med. 2022, 9:1109445. 10.3389\/fcvm.2022.1109445","journal-title":"Front Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136298","article-title":"Homocysteine attack on vascular endothelium: old and new mechanisms","volume":"26","author":"Hurjui LL","year":"2025","unstructured":"Hurjui LL, Tarniceriu CC, Serban DN, et al.. Homocysteine attack on vascular endothelium: old and new mechanisms. Int J Mol Sci. 2025, 26:6298. 10.3390\/ijms26136298","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0003319718787366","article-title":"Subclinical atherosclerosis in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"70","author":"Wang P","year":"2019","unstructured":"Wang P, Xu YY, Lv TT, Guan SY, Li XM, Li XP, Pan HF. Subclinical atherosclerosis in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Angiology. 2019, 70:141-59. 10.1177\/0003319718787366","journal-title":"Angiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02280-5","article-title":"Abnormal vascular thickness and stiffness in young adults with type 1 diabetes: new insights from cutting-edge ultrasound modalities","volume":"23","author":"De Biasio MJ","year":"2024","unstructured":"De Biasio MJ, Furman M, Clarke A, et al.. Abnormal vascular thickness and stiffness in young adults with type 1 diabetes: new insights from cutting-edge ultrasound modalities. Cardiovasc Diabetol. 2024, 23:178. 10.1186\/s12933-024-02280-5","journal-title":"Cardiovasc Diabetol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01537-1","article-title":"Arterial stiffness in patients with type 1 diabetes and its comparison to cardiovascular risk evaluation tools","volume":"21","author":"Helleputte S","year":"2022","unstructured":"Helleputte S, Van Bortel L, Verbeke F, Op 't Roodt J, Calders P, Lapauw B, De Backer T. Arterial stiffness in patients with type 1 diabetes and its comparison to cardiovascular risk evaluation tools. Cardiovasc Diabetol. 2022, 21:97. 10.1186\/s12933-022-01537-1","journal-title":"Cardiovasc Diabetol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx N","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, et al.. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023, 44:4043-140. 10.1093\/eurheartj\/ehad192","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-3104","article-title":"Associations of microvascular complications with the risk of cardiovascular disease in type 1 diabetes","volume":"44","author":"Gubitosi-Klug R","year":"2021","unstructured":"Gubitosi-Klug R, Gao X, Pop-Busui R, et al.. Associations of microvascular complications with the risk of cardiovascular disease in type 1 diabetes. Diabetes Care. 2021, 44:1499-505. 10.2337\/dc20-3104","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.30710","article-title":"Cardiometabolic risk factors and incident cardiovascular disease events in women vs men with type 1 diabetes","volume":"5","author":"Braffett BH","year":"2022","unstructured":"Braffett BH, Bebu I, El Ghormli L, et al.. Cardiometabolic risk factors and incident cardiovascular disease events in women vs men with type 1 diabetes. JAMA Netw Open. 2022, 5:e2230710. 10.1001\/jamanetworkopen.2022.30710","journal-title":"JAMA Netw Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107651","article-title":"Cardiovascular disease in young people with type 1 diabetes: search for cardiovascular biomarkers","volume":"34","author":"Sch\u00e4fer M","year":"2020","unstructured":"Sch\u00e4fer M, Nadeau KJ, Reusch JE. Cardiovascular disease in young people with type 1 diabetes: search for cardiovascular biomarkers. J Diabetes Complications. 2020, 34:107651. 10.1016\/j.jdiacomp.2020.107651","journal-title":"J Diabetes Complications"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuad091","article-title":"A comprehensive review and meta-regression analysis of randomized controlled trials examining the impact of vitamin B12 supplementation on homocysteine levels","volume":"82","author":"Sohouli MH","year":"2024","unstructured":"Sohouli MH, Almuqayyid F, Alfardous Alazm A, et al.. A comprehensive review and meta-regression analysis of randomized controlled trials examining the impact of vitamin B12 supplementation on homocysteine levels. Nutr Rev. 2024, 82:726-37. 10.1093\/nutrit\/nuad091","journal-title":"Nutr Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s43044-024-00460-y","article-title":"Association between homocysteine and coronary artery disease-trend over time and across the regions: a systematic review and meta-analysis","volume":"76","author":"Unadkat SV","year":"2024","unstructured":"Unadkat SV, Padhi BK, Bhongir AV, et al.. Association between homocysteine and coronary artery disease-trend over time and across the regions: a systematic review and meta-analysis. Egypt Heart J. 2024, 76:29. 10.1186\/s43044-024-00460-y","journal-title":"Egypt Heart J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202309_33784","article-title":"Homocysteine as a predictor and prognostic marker of atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"27","author":"Habib SS","year":"2023","unstructured":"Habib SS, Al-Khlaiwi T, Almushawah A, Alsomali A, Habib SA. Homocysteine as a predictor and prognostic marker of atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2023, 27:8598-608. 10.26355\/eurrev_202309_33784","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2023.2023-12-12","article-title":"Cardiovascular risk factors in adolescents with type 1 diabetes: prevalence and gender differences","volume":"16","author":"Vurall\u0131 D","year":"2024","unstructured":"Vurall\u0131 D, Jalilova L, Alika\u015fifo\u011flu A, \u00d6z\u00f6n ZA, G\u00f6n\u00e7 EN, Kandemir N. Cardiovascular risk factors in adolescents with type 1 diabetes: prevalence and gender differences. J Clin Res Pediatr Endocrinol. 2024, 16:11-20. 10.4274\/jcrpe.galenos.2023.2023-12-12","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41571","article-title":"Early detection of subclinical atherosclerosis: hyperhomocysteinemia as a promising marker in adolescents with vitamin B deficiency","volume":"15","author":"Shirode PS","year":"2023","unstructured":"Shirode PS, Parekh AD, Patel VV, et al.. Early detection of subclinical atherosclerosis: hyperhomocysteinemia as a promising marker in adolescents with vitamin B deficiency. Cureus. 2023, 15:e41571. 10.7759\/cureus.41571","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2005.01560.x","article-title":"Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study","volume":"258","author":"Soedamah-Muthu SS","year":"2005","unstructured":"Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study. J Intern Med. 2005, 258:450-9. 10.1111\/j.1365-2796.2005.01560.x","journal-title":"J Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.113708","article-title":"Reduced total plasma homocyst(e)ine in children and adolescents with type 1 diabetes","volume":"138","author":"Wiltshire E","year":"2001","unstructured":"Wiltshire E, Thomas DW, Baghurst P, Couper J. Reduced total plasma homocyst(e)ine in children and adolescents with type 1 diabetes. J Pediatr. 2001, 138:888-93. 10.1067\/mpd.2001.113708","journal-title":"J Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"4","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Med. 2007, 4:e296. 10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis M","year":"2007","unstructured":"de Onis M, Onyango AW, Borghi E, et al.. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007, 85:660-667. 10.2471\/BLT.07.043497","journal-title":"Bull World Health Organ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.09.001","article-title":"Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms","volume":"46","author":"Verg\u00e8s B","year":"2020","unstructured":"Verg\u00e8s B. Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms. Diabetes Metab. 2020, 46:442-9. 10.1016\/j.diabet.2020.09.001","journal-title":"Diabetes Metab"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes versus type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea D","year":"2017","unstructured":"Dabelea D, Stafford JM, Mayer-Davis EJ, et al.. Association of type 1 diabetes versus type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA. 2017, 317:825-35. 10.1001\/jama.2017.0686","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan DM","year":"1993","unstructured":"Nathan DM, Genuth S, Lachin J, et al.. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329:977-86. 10.1056\/NEJM199309303291401","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2013.204222","article-title":"Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort","volume":"59","author":"Bailey D","year":"2013","unstructured":"Bailey D, Colantonio D, Kyriakopoulou L, Cohen AH, Chan MK, Armbruster D, Adeli K. Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem. 2013, 59:1393-405. 10.1373\/clinchem.2013.204222","journal-title":"Clin Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/522870-plasma-homocysteine-as-a-biomarker-for-cardiovascular-risk-stratification-in-children-and-adolescents-with-type-1-diabetes-mellitus-a-cross-sectional-study-from-western-algeria","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:15:17Z","timestamp":1787685317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/522870-plasma-homocysteine-as-a-biomarker-for-cardiovascular-risk-stratification-in-children-and-adolescents-with-type-1-diabetes-mellitus-a-cross-sectional-study-from-western-algeria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.115169","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}